Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma
Main Authors: | Zhu, Zhengfei, Yu, Weiwei, Fu, Xiaolong, Sun, Menghong, Wei, Qiao, Li, Dali, Chen, Haiquan, Xiang, Jiaqing, Li, Hecheng, Zhang, Yawei, Zhao, Weixin, Zhao, Kuaile |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559941/ |
Similar Items
-
High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy
by: Wang, Chunyu, et al.
Published: (2015) -
Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction
by: Li, Hecheng, et al.
Published: (2009) -
Expression and phosphorylation of stathmin correlate with cell migration in esophageal squamous cell carcinoma
by: LIU, FEI, et al.
Published: (2013) -
DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis
by: Ji, Yan-Mei, et al.
Published: (2016) -
Association of insulin-like growth factor-binding protein-3 with radiotherapy response and prognosis of esophageal squamous cell carcinoma
by: Luo, Li-Ling, et al.
Published: (2015)